Barclay ML - Search Results

1

Evaluation of the Homogenous Mobility Shift Assay for Infliximab and Adalimumab Anti-drug Antibody Detection in the Clinical Laboratory.

Keating PE, Hock BD, Chin PKL, O'Donnell JL, Barclay ML. Keating PE, et al. Among authors: barclay ml. Ther Drug Monit. 2024 Apr 9. doi: 10.1097/FTD.0000000000001200. Online ahead of print. Ther Drug Monit. 2024. PMID: 38648648

2

Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care.

Bayoumy AB, Mulder CJJ, Ansari AR, Barclay ML, Florin T, Kiszka-Kanowitz M, Derijks L, Sharma V, de Boer NKH. Bayoumy AB, et al. Among authors: barclay ml. Indian J Gastroenterol. 2024 Feb;43(1):36-47. doi: 10.1007/s12664-024-01529-x. Epub 2024 Feb 21. Indian J Gastroenterol. 2024. PMID: 38383877 Free PMC article. Review.

3

Relationship Between Adalimumab Concentrations, Antidrug Antibodies, and Disease Activity in Rheumatoid Arthritis: A Cross-Sectional Observational Study.

Stamp LK, Keating P, Frampton C, Barclay ML, Fanning N, Millier M, Hessian PA, O'Donnell JL. Stamp LK, et al. Among authors: barclay ml. J Rheumatol. 2024 Mar 1;51(3):242-249. doi: 10.3899/jrheum.2023-0706. J Rheumatol. 2024. PMID: 38224989

4

Editorial: Monitoring methotrexate polyglutamates in Crohn's disease.

Barclay ML, Stamp LK. Barclay ML, et al. Aliment Pharmacol Ther. 2024 Jan;59(1):118-119. doi: 10.1111/apt.17743. Aliment Pharmacol Ther. 2024. PMID: 38085937 No abstract available.

5

Four-year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing.

Keating PE, Hock BD, Smith SM, Chin PKL, O'Donnell JL, Barclay ML. Keating PE, et al. Among authors: barclay ml. Intern Med J. 2023 Nov;53(11):2123-2127. doi: 10.1111/imj.16264. Intern Med J. 2023. PMID: 37997271 Review.

6

Immediate effect of caffeine on sympathetic nerve activity: why coffee is safe? A single-centre crossover study.

Butler JM, Frampton CM, Moore G, Barclay ML, Jardine DL. Butler JM, et al. Among authors: barclay ml. Clin Auton Res. 2023 Dec;33(6):623-633. doi: 10.1007/s10286-023-00967-5. Epub 2023 Aug 20. Clin Auton Res. 2023. PMID: 37598402 Free PMC article.

7

Changes in inpatient medicine prescribing during COVID-19 lockdown.

Wang MY, Barclay ML, Chin PKL, Doogue MP. Wang MY, et al. Among authors: barclay ml. Intern Med J. 2023 Jun;53(6):917-922. doi: 10.1111/imj.15996. Epub 2023 Jan 20. Intern Med J. 2023. PMID: 36510392 Free PMC article.

8

Helicobacter pylori in New Zealand: current diagnostic trends and related costs.

Kubovy J, Barclay ML. Kubovy J, et al. Among authors: barclay ml. N Z Med J. 2022 Sep 23;135(1562):48-55. N Z Med J. 2022. PMID: 36137766

9

Rectally Administrated Thioguanine for Distal Ulcerative Colitis: A Multicenter Case Series.

Crouwel F, Simsek M, van Doorn AS, Mulder CJJ, Buiter HJC, Barclay ML, Florin TH, de Boer NK. Crouwel F, et al. Among authors: barclay ml. Inflamm Bowel Dis. 2023 Jun 1;29(6):1000-1004. doi: 10.1093/ibd/izac195. Inflamm Bowel Dis. 2023. PMID: 36099056 Free PMC article. No abstract available.

10

Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children.

Liu Z, Julsgaard M, Zhu X, Martin J, Barclay ML, Cranswick N, Gibson PR, Gearry RB, van der Giessen J, Connor SJ, Rosella O, Grosen A, Toong C, Flanagan E, Wieringa JW, Janneke van der Woude C, Bell SJ; CARINA Study Group. Liu Z, et al. Among authors: barclay ml. J Crohns Colitis. 2022 Dec 5;16(12):1835-1844. doi: 10.1093/ecco-jcc/jjac093. J Crohns Colitis. 2022. PMID: 35779236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page